Home/Filings/4/0001209191-14-017188

4//SEC Filing

ARATANA THERAPEUTICS, INC. 4

Accession 0001209191-14-017188

CIK 0001509190operating

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 2:57 PM ET

Size

28.9 KB

Accession

0001209191-14-017188

Insider Transaction Report

Form 4

Period: 2014-03-03

ARATANA THERAPEUTICS, INC.PETX

MPM BIOVENTURES V, L.P.

10% Owner

Transactions

Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)

Scopa James Paul

10% Owner

Transactions

Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)

Foley Todd

10% Owner

Transactions

Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)

MPM BIOVENTURES V GP LLC

10% Owner

Transactions

Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)

MPM BIOVENTURES V LLC

10% Owner

Transactions

Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)

EVNIN LUKE

10% Owner

Transactions

Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)

KAILIAN VAUGHN M

10% Owner

Transactions

Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)

GADICKE ANSBERT

10% Owner

Transactions

Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)
Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)

MPM ASSET MANAGEMENT INVESTORS BV5 LLC

10% Owner

Transactions

Other
Common Stock
2014-03-03+20,876→ 38,386 total(indirect: By Luke Evnin)
Other
Common Stock
2014-03-03+15,310→ 17,937 total(indirect: By Vaughn Kailian)
Other
Common Stock
2014-03-03+12,247→ 12,393 total(indirect: By Trust)
Other
Common Stock
2014-03-03−1,000,000→ 3,351,048 total(indirect: See Footnote)
Other
Common Stock
2014-03-03+20,876→ 26,713 total(indirect: By Ansbert Gadicke)
Other
Common Stock
2014-03-03+20,876→ 22,767 total(indirect: By James Paul Scopa)
Other
Common Stock
2014-03-03+37,117→ 37,117 total(indirect: By LLC)

Footnotes (5)

[F1]Pro-rata distribution of partnership interests.
[F2]The shares were distributed as follows: 962,533 by MPM BioVentures V, L.P. ("BV V") and 37,467 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian, James Paul Scopa and Todd Foley are the members of BV LLC. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
[F3]The shares are held as follows: 3,225,494 by BV V and 125,554 by AM BV5. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
[F4]Includes 2,627 shares held by The Vaughn and Patricia Kailian Revocable Trust u/a/dtd 12/18/1992, of which the Reporting Person is trustee.
[F5]MPM Founders LLC ("MPM Founders") is the managing member of MPM Capital LLC, and Messrs. Evnin and Gadicke are members of MPM Founders. Messrs. Evnin and Gadicke disclaim beneficial ownership of the shares held by MPM Capital LLC except to the extent of their respective pecuniary interests therein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ARATANA THERAPEUTICS, INC.

CIK 0001509190

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001509190

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 2:57 PM ET
Size: 28.9 KB

View on SEC.gov